1892
|
1-NM-PP1
|
Potent tyrosine kinase inhibitor (TKI) of multiple targets (Src, Fyn, Abl, CDK, Trk) |
€95.00
|
1698
|
A 770041
|
Orally active src-family selective lck inhibitor |
€140.00
|
4141
|
Acalabrutinib
|
Orally active, irreversible, and highly selective second-generation BTK inhibitor |
Inquire
|
1378
|
AG 490
|
JAK2 inhibitor |
€65.00
|
2031
|
AIM 100
|
Specific inhibitor of Ack1 tyrosine kinase (also known as TNK2) |
€95.00
|
3997
|
ASN-002
|
Potent dual inhibitor of SYK and pan-JAK kinases |
Inquire
|
2219
|
AT 9283
|
Multitargeted kinase inhibitor (Aurora A/B, JAK2/3, and BCR-Abl) |
€85.00
|
2226
|
AVL 292
|
Potent, selective, covalent BTK inhibitor |
€110.00
|
1778
|
AZ 960
|
JAK2 inhibitor |
€95.00
|
3855
|
AZD-4205
|
Selective and ATP-competitive inhibitor of JAK1 |
Inquire
|
1456
|
AZD0530 difumarate
|
Inhibitor of SRC and ABL tyrosine kinases |
€70.00
|
1955
|
Baricitinib
|
Inhibitor of JAK1 and JAK2 |
€70.00
|
3813
|
BMS-911543
|
Potent, selective and orally active inhibitor of JAK2 |
Inquire
|
3671
|
CEP-33779
|
Potent, selective and orally bioavailable JAK2 inhibitor |
€95.00
|
2775
|
Cerdulatinib
|
Orally active dual Syk/JAK inhibitor |
€85.00
|
2018
|
CGI 1746
|
Inhibitor of Bruton's tyrosine kinase (BTK) |
€50.00
|
2097
|
CGP 77675
|
Src Family kinase (SFK) inhibitor |
€65.00
|
1338
|
CP 690550
|
JAK3 inhibitor |
€60.00
|
3861
|
Decernotinib
|
Potent and selective,orally bioavailable Janus kinase 3 (JAK3) inhibitor |
Inquire
|
2574
|
Defactinib
|
Orally available second generation inhibitor of FAK and PYK2 |
€80.00
|
4091
|
Deucravacitinib
|
Potent, highly selective, allosteric and orally bioavailable TYK2 inhibitor |
€150.00
|
4006
|
GLPG-0634
|
The first orally-available, selective inhibitor of JAK1 |
Inquire
|
4153
|
GS-9973
|
Selective Syk inhibitor |
Inquire
|
3717
|
GSK2256098
|
FAK inhibitor |
Inquire
|
1843
|
JAK2 inhibitor 13
|
JAK2 inhibitor |
€110.00
|
2862
|
LFM-A13
|
Inhibitor of Bruton's tyrosine kinase (BTK) |
€90.00
|
3270
|
Lj-1-60
|
Fyn inhibitor targeting the Fyn/Stat3 pathway |
€90.00
|
2554
|
LY 2784544
|
Potent, selective and ATP-competitive inhibitor of mutated janus kinase 2 (JAK2V617F) |
€95.00
|
1494
|
MK 1775
|
Wee1 kinase inhibitor |
€80.00
|
1941
|
MLR 1023
|
Selective allosteric activator of Lyn kinase |
€95.00
|